Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Potassium voltage-gated channel subfamily H member 2 (KCNH2), commonly referred to as hERG, is a protein that forms the alpha subunit of the rapid delayed rectifier potassium channel (IKr) in the heart. This channel is fundamental for the repolarization phase of the cardiac action potential, effectively resetting the electrical state of the heart after each beat to allow for subsequent contraction [UniProt Q12809]. Proper functioning of KCNH2 is vital for maintaining a stable heart rhythm, and genetic mutations in the KCNH2 gene are the primary cause of Long QT syndrome type 2 (LQT2) [NCBI Gene 3757].
Beyond its physiological role, KCNH2 is highly susceptible to inhibition by a wide variety of structurally diverse drugs, including antihistamines, antipsychotics, and antibiotics [PubChem CID 3757]. This unintended drug-target interaction can lead to drug-induced Long QT syndrome and life-threatening ventricular arrhythmias such as Torsades de Pointes [StatPearls NBK554411]. Consequently, screening for hERG channel inhibition is a mandatory safety requirement in modern drug discovery to prevent cardiotoxicity [FDA/ICH E14/S7B].
Blockade of the rapid delayed rectifier potassium current (IKr)
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Potassium voltage-gated channel subfamily H member 2 (KCNH2).